Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study

by Mehta, Rashmi, Kelleher, Dennis, Preece, Andrew, Hughes, Stephen, Crater, Glenn
Published 2013

Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

by Church, Alison, Beerahee, Misba, Brooks, Jean, Mehta, Rashmi, Shah, Palvi
Published 2014

A technique to prevent overfilling of viewing chamber of intravenous infusion kit

by Kakani, Lovelesh, Sharma, Surinder M, Mehta, Rashmi C, Singh, Gurpreet
Published 2014

Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers

by Brealey, Noushin, Gupta, Ashutosh, Renaux, Jessica, Mehta, Rashmi, Allen, Ann, Henderson, Alex
Published 2015

Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized study

by Mehta, Rashmi, Hardes, Kelly, Brealey, Noushin, Tombs, Lee, Preece, Andrew, Kelleher, Dennis
Published 2014

Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD...

by Beier, Jutta, van Noord, Jan, Deans, Amanda, Brooks, Jean, Maden, Claire, Baggen, Suus, Mehta, Rashmi, Cahn, Anthony
Published 2012

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Umeclidinium and Vilanterol Alone and in Combination: A Randomized Crossover Trial

by Kelleher, Dennis L., Mehta, Rashmi S., Jean-Francois, Bernadette M., Preece, Andrew F., Blowers, James, Crater, Glenn D., Thomas, Paul
Published 2012

Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial

by Hu, Chaoying, Jia, Jingying, Dong, Kelly, Luo, Linda, Wu, Kai, Mehta, Rashmi, Peng, Jack, Ren, Yan, Gross, Annette, Yu, Hui
Published 2015